1. Home
  2. VOXR vs SCTX Comparison

VOXR vs SCTX Comparison

Compare VOXR & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vox Royalty Corp.

VOXR

Vox Royalty Corp.

SELL

Current Price

$4.21

Market Cap

339.1M

ML Signal

SELL

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

SELL

Current Price

$15.55

Market Cap

297.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VOXR
SCTX
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.1M
297.2M
IPO Year
2022
2026

Fundamental Metrics

Financial Performance
Metric
VOXR
SCTX
Price
$4.21
$15.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$7.67
★ $57.00
AVG Volume (30 Days)
★ 526.9K
360.1K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
★ 1.37%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$102.08
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.99
$13.50
52 Week High
$6.70
$39.60

Technical Indicators

Market Signals
Indicator
VOXR
SCTX
Relative Strength Index (RSI) 36.18 42.02
Support Level $4.13 $13.90
Resistance Level $5.16 $18.30
Average True Range (ATR) 0.20 1.59
MACD -0.03 0.21
Stochastic Oscillator 10.16 37.91

Price Performance

Historical Comparison
VOXR
SCTX

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty and streaming company. It holds a diversified portfolio of several royalties and streams, including producing and development stage assets, with primary exposure to gold and select industrial metals across top-tier mining jurisdictions. Vox is organized into two operating segments, consisting of acquiring and managing royalty interests; and acquiring and managing streams and other interests. Maximum revenue is generated from its Royalty Interests segment. The majority of the company's portfolio of royalty, streams, and other interests by asset count is located in Australia, Canada, and the United States, of which the maximum revenue is derived from its assets in Australia.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: